The Australian medical community is excited with the emergence of retatrutide, a novel dual GIP and GLP-1 receptor showing significant results in early trials for treating obesity. This treatment suggests a substantial approach to combat excess weight, potentially exceeding existing treatments like semaglutide. While availability is still limited a

Regarding persistent problems going to sleep , medicated sleeping pills can appear like a tempting answer . However, they should truly be considered a last resort, due to the possible side effects and the necessity of addressing the core reasons of one's sleep disorder. Exploring non-medication methods, including CBT and lifestyle modifications, i